Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-day rTMS + D-cycloserine to Treat PTSD in First Responders
NCT07773935Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of d-cycloserine in post-traumatic stress disorder (PTSD). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
d-cycloserine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT07773935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773935.